Descrizione business
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Dr. Daniel Koller |
| Consiglio di amministrazione |
| Dr. Thomas von Planta, Laura Hamill, Dr. Pearl Huang, Prof. Dr. Mads Krogsgaard Thomsen, Camilla Soenderby |
| Consiglio di sorveglianza |
| Dr. Clive Meanwell |
Dati aziendali
| Name: |
BB Biotech AG |
| Indirizzo: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
| Telefono: |
+41-52-624-0845 |
| Fax: |
- |
| E-mail: |
info@bbbiotech.com
|
| Internet: |
www.bbbiotech.com |
| Industria: |
Financial |
| Settore: |
Specialty Finance |
| Sub settore: |
Diversified Financial |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
97.00% |
| Data dell'IPO: |
10/12/1997 |
Rapporti con gli investitori
| Name: |
Dr. Silvia Siegfried-Schanz |
| IR telefono: |
+41-44-267-7266 |
| IR Fax: |
- |
| IR e-mail: |
ssc@bellevue.ch
|
